Unpublished Paper
A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf® Capsules Twice-A-Day
Sponsored by Lifecycle Pharma
(2000)
Disciplines
Publication Date
2000
Citation Information
Gregory Smallwood. "A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf® Capsules Twice-A-Day" Sponsored by Lifecycle Pharma (2000) Available at: http://works.bepress.com/gregory_smallwood/10/